VitMode

Helicobacter pylori: Symptoms, Diagnosis, and Treatment of Infection

Helicobacter pylori is a bacterium that colonizes the stomach of nearly half the world's population, in most cases without symptoms. The problem is that in some infected people it leads to chronic inflammation of the stomach lining, peptic ulcer disease, and, in rare cases, gastric cancer — and rising antibiotic resistance means standard treatment increasingly fails. We check how to recognize an infection, when treatment actually reduces gastric cancer risk, and when antibiotic therapy "just in case" misses the point.

Redakcja VitMode — Żywienie, suplementy i treningthe VitMode editorial team, no individual bylinesPublished14 min read
How this article was made
Author
Redakcja VitMode — Żywienie, suplementy i trening — the VitMode editorial team, no individual bylines
Method
Prepared from primary sources: clinical trials, meta-analyses and guidelines. We describe study findings separately from our interpretation.
Source verification
Cited PubMed papers are automatically checked for a matching identifier, title and publication year.
Medical review
none — this article has not been reviewed by a physician
Last updated

The content is educational and does not replace medical advice. Read the full editorial process

Table of contents

A bacterium nearly half the world lives with — and mostly doesn't even know it

Helicobacter pylori is a spiral-shaped Gram-negative bacterium, one of the few able to survive in the stomach's highly acidic environment thanks to its production of urease, which locally neutralizes hydrochloric acid. Infection usually occurs in childhood, via the fecal-oral or oral-oral route, and without treatment can persist for decades, even a lifetime.

A key, often overlooked fact: in most infected people, H. pylori never causes any symptoms at all. The bacterium can silently colonize the stomach for decades. This makes the question "is it worth looking for and treating infection in an asymptomatic person" considerably more complex than it might seem — and we return to it later in the article.

Symptoms — and why their absence doesn't mean the absence of infection

Diagnosis: which tests make sense, and which give false results

TestCharacteristics
Urea breath test (UBT)Non-invasive, high sensitivity and specificity, the gold standard for confirming eradication after treatment
H. pylori stool antigen testNon-invasive, accuracy comparable to the breath test, a good choice for initial diagnosis and post-treatment follow-up
Serology test (blood antibodies)Detects antibodies that can persist for months after the infection is cured — not useful for confirming eradication, limited diagnostic value
Endoscopy with biopsy (urease test, histopathology)Invasive, but necessary in the presence of alarm symptoms — allows simultaneous assessment of the stomach lining and exclusion of other causes of symptoms
Diagnostic methods for H. pylori infection

Why treatment matters: the link to peptic ulcer disease and gastric cancer

H. pylori is the main cause of gastric and duodenal ulcer disease — it triggers chronic inflammation of the stomach lining, which in some infected people leads to the formation of defects. A far more serious, though rarer, consequence is the link to gastric cancer: the World Health Organization classifies H. pylori as a class I carcinogen, and chronic infection is the strongest known risk factor for this cancer.

Treatment: why standard triple therapy is losing effectiveness

For decades, the standard treatment was triple therapy: a combined with two antibiotics, most often clarithromycin and amoxicillin, for 7-14 days. The problem is that this therapy's effectiveness has been systematically declining as bacterial resistance to clarithromycin rises — in many regions of the world it has already crossed the threshold at which triple therapy stops being a reliable first-line choice.

In practice, this means a physician deciding on a treatment regimen should factor in local antibiotic resistance data rather than automatically reaching for a decade-old regimen. Bismuth quadruple therapy usually lasts 10-14 days and comes with a somewhat higher number of side effects (including black stool discoloration from bismuth preparations, which is harmless but can be alarming to patients), but achieves higher eradication success under conditions of rising resistance.

Check your profile

Not sure which supplements actually make sense for you?

Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.

Takes about 2 minutesBased on scientific evidence

Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.

How effective treatment is in practice

of newer studies show that standard triple therapy's effectiveness in intention-to-treat analysis now averages around 74%, while quadruple therapy reaches about 82-83%. In other words: even with appropriately chosen treatment, the first eradication attempt fails in some patients, requiring second-line treatment, ideally selected based on antibiotic susceptibility testing where available.

Who's worth diagnosing and treating, and when it's unnecessary

Myth

Since H. pylori increases gastric cancer risk, everyone should be tested and, if infection is detected, treated with antibiotics immediately — regardless of symptoms.

Fact

Guidelines don't recommend universal, routine screening of the entire asymptomatic general population in countries with low gastric cancer incidence — the benefit of treatment (measured by ) is much smaller there than in high-risk populations, and every course of antibiotics carries its own risks (side effects, impact on the microbiota, selective pressure favoring bacterial resistance). Diagnosis and treatment are most strongly warranted in people with dyspeptic symptoms, a history of peptic ulcer disease, unexplained iron-deficiency anemia, family history of gastric cancer, or origin from high-incidence regions.

Limitations of the available data

Our editorial recommendation

H. pylori is a rare example of a situation where eradicating a single bacterial pathogen has a documented, though population-dependent, impact on the risk of a specific cancer — a solid argument for diagnosis in people with justified indications. At the same time, rising antibiotic resistance means "just in case" treatment, without considering local resistance data, increasingly ends in failed eradication and unnecessary antibiotic exposure.

A sensible approach is targeted diagnosis of people with genuine indications — symptoms, a history of peptic ulcer disease, unexplained anemia, or family history — treatment consistent with current guidelines that account for local resistance, and mandatory confirmation of eradication with a follow-up test after completing therapy.

The most common mistake in approaching H. pylori isn't a lack of treatment, but a lack of verifying it — antibiotic therapy without confirmed eradication is half a solution that's easy to mistake for the whole thing.
VitMode editorial team

Frequently asked questions

There's no clear consensus on universal screening and treatment of the entire asymptomatic population, especially in countries with low gastric cancer incidence. Treatment is most strongly warranted in people with symptoms, a history of peptic ulcer disease, unexplained anemia, or family history of gastric cancer.

A urea breath test or stool antigen test, performed at least 4 weeks after completing antibiotic therapy and after stopping the proton pump inhibitor. A serology (blood) test isn't suitable for this purpose, since antibodies can persist for months after the infection is cured.

Mainly because of rising bacterial resistance to clarithromycin, one of the antibiotics most commonly used in classic triple therapy. In high-resistance regions, current guidelines (the Maastricht VI/Florence consensus, 2022) recommend bismuth quadruple therapy as first-line treatment.

No — the large majority of infected people never develop gastric cancer. However, H. pylori is the strongest known risk factor for this cancer, and a meta-analysis of studies (Ford et al., 2014) showed that eradication reduces the risk by about a third (RR 0.66) in asymptomatic people, with a clearer benefit in populations with higher baseline risk.

Yes — proton pump inhibitors can produce false-negative results on the breath test and stool test. It's recommended to stop them at least 2 weeks before testing, and antibiotics and bismuth preparations at least 4 weeks before.

Unintended weight loss, blood in stool or vomit, difficulty swallowing, persistent vomiting, and unexplained anemia are alarm symptoms requiring an urgent gastroenterology consultation, not self-treatment with acid-reducing medication.

Standard regimens last 10-14 days. Bismuth quadruple therapy, now often preferred because of clarithromycin resistance, comes with a somewhat higher number of side effects, including harmless black stool discoloration from bismuth preparations, which is sometimes mistaken for bleeding.

Yes — a systematic review of 224 studies (Li et al., 2023) showed a decline in global infection prevalence from 58.2% in 1980-1990 to 43.1% in 2011-2022, mainly thanks to improved sanitation and access to drinking water, though prevalence still varies significantly between regions of the world.

Sources (3)

Sources are numbered. PubMed items are automatically verified (identifier, title, year).

  1. 1Li et al. 2023 — The Lancet Gastroenterology & HepatologyPubMed
  2. 2Ford et al. 2014 — BMJPubMed
  3. 3Malfertheiner et al. 2022 — Gut (Maastricht VI/Florence consensus)PubMed
VM

Redakcja VitMode — Żywienie, suplementy i trening

VitMode editorial team — no individual bylines; content based on primary sources

VitMode Editorial — Nutrition, Supplements and Training is the VitMode editorial team responsible for: nutrition, supplements, interactions and training. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.

Explore the topic further

Related topics from the VitMode knowledge base — pick the area you care about.

This article

Helicobacter pylori: Symptoms, Diagnosis, and Treatment of Infection

Tools for this topic

Your entries stay in your browser and are never sent anywhere. This is a notebook, not a diagnostic tool — it does not diagnose or recommend treatment. Discuss results with your doctor.

Questions readers often ask

Short answers from related articles — click to read more.

What are the first symptoms of a stomach ulcer?

Most often it is pain or burning in the upper abdomen, a feeling of fullness, nausea, early satiety and heartburn. The pain of a duodenal ulcer more often occurs when fasting or at night and eases after eating, whereas gastric…

From the article: Stomach and Duodenal Ulcer: Symptoms, Causes, Diagnosis and Treatment
How does functional dyspepsia differ from ordinary stomach ache?

Functional dyspepsia is a chronic, recurrent syndrome of upper abdominal symptoms (pain, burning, fullness after meals, early satiety) lasting at least three months, with no organic cause after routine testing. Occasional stomach…

From the article: Functional Dyspepsia: Upper Abdominal Pain and Fullness Without an Ulcer — Symptoms, Rome IV Criteria and Treatment
What are the first symptoms of dysphagia?

Most often it is a feeling of food holding up behind the breastbone or in the throat, the need to wash down bites, coughing or choking while eating, and sometimes regurgitation. In oropharyngeal dysphagia there is also difficulty…

From the article: Difficulty Swallowing (Dysphagia): Causes, Tests and When to See a Doctor Urgently
Does a celiac test need to be done while eating gluten?

Yes, that's a key condition for the test's reliability. Diagnostic antibodies for celiac disease are produced in response to gluten in the diet — eliminating it beforehand can lower their levels and produce a false-negative…

From the article: Celiac Disease vs. Non-Celiac Gluten Sensitivity: How Do They Differ and Get Diagnosed?

Did not find your answer? Write to us — we do not give individual advice, but we can point to reliable sources. Ask the editors

Related knowledge base entries